Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Structure and function of renal macrophages and dendritic cells from lupus-prone mice.

Sahu R, Bethunaickan R, Singh S, Davidson A.

Arthritis Rheumatol. 2014 Jun;66(6):1596-607. doi: 10.1002/art.38410.

2.

A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.

Bethunaickan R, Berthier CC, Ramanujam M, Sahu R, Zhang W, Sun Y, Bottinger EP, Ivashkiv L, Kretzler M, Davidson A.

J Immunol. 2011 Apr 15;186(8):4994-5003. doi: 10.4049/jimmunol.1003010. Epub 2011 Mar 16.

3.

Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.

Lourenço EV, Wong M, Hahn BH, Palma-Diaz MF, Skaggs BJ.

Arthritis Rheumatol. 2014 Mar;66(3):674-85. doi: 10.1002/art.38259.

4.

Dexamethasone prodrug treatment prevents nephritis in lupus-prone (NZB × NZW)F1 mice without causing systemic side effects.

Yuan F, Nelson RK, Tabor DE, Zhang Y, Akhter MP, Gould KA, Wang D.

Arthritis Rheum. 2012 Dec;64(12):4029-39. doi: 10.1002/art.34667.

5.

Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks.

Bethunaickan R, Berthier CC, Zhang W, Kretzler M, Davidson A.

PLoS One. 2013 Oct 22;8(10):e77489. doi: 10.1371/journal.pone.0077489. eCollection 2013.

6.

Renal F4/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy.

Cao Q, Wang Y, Wang XM, Lu J, Lee VW, Ye Q, Nguyen H, Zheng G, Zhao Y, Alexander SI, Harris DC.

J Am Soc Nephrol. 2015 Feb;26(2):349-63. doi: 10.1681/ASN.2013121336. Epub 2014 Jul 10.

7.

Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension.

Kashyap S, Warner GM, Hartono SP, Boyilla R, Knudsen BE, Zubair AS, Lien K, Nath KA, Textor SC, Lerman LO, Grande JP.

Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F372-84. doi: 10.1152/ajprenal.00131.2015. Epub 2015 Dec 9.

10.

CCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice.

Bignon A, Gaudin F, Hémon P, Tharinger H, Mayol K, Walzer T, Loetscher P, Peuchmaur M, Berrebi D, Balabanian K.

J Immunol. 2014 Feb 1;192(3):886-96. doi: 10.4049/jimmunol.1300123. Epub 2013 Dec 23.

11.

Renal dendritic cells adopt a pro-inflammatory phenotype in obstructive uropathy to activate T cells but do not directly contribute to fibrosis.

Snelgrove SL, Kausman JY, Lo C, Lo C, Ooi JD, Coates PT, Hickey MJ, Holdsworth SR, Kurts C, Engel DR, Kitching AR.

Am J Pathol. 2012 Jan;180(1):91-103. doi: 10.1016/j.ajpath.2011.09.039. Epub 2011 Nov 8.

PMID:
22079432
12.

Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus.

Benigni A, Caroli C, Longaretti L, Gagliardini E, Zoja C, Galbusera M, Moioli D, Romagnani P, Tincani A, Andreoli L, Remuzzi G.

Arthritis Rheum. 2007 May;56(5):1569-78.

13.

Dendritic and stromal cells from the spleen of lupic mice present phenotypic and functional abnormalities.

Gleisner MA, Reyes P, Alfaro J, Solanes P, Simon V, Crisostomo N, Sauma D, Rosemblatt M, Bono MR.

Mol Immunol. 2013 Jul;54(3-4):423-34. doi: 10.1016/j.molimm.2013.01.011. Epub 2013 Feb 21.

PMID:
23428837
14.

Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice.

Trigunaite A, Khan A, Der E, Song A, Varikuti S, Jørgensen TN.

Arthritis Rheum. 2013 Sep;65(9):2392-402. doi: 10.1002/art.38048.

15.

IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.

Shiroiwa W, Tsukamoto K, Ohtsuji M, Lin Q, Ida A, Kodera S, Ohtsuji N, Nakamura K, Tsurui H, Kinoshita K, Nishimura H, Shirai T, Hirose S.

Int Immunol. 2007 Feb;19(2):175-83. Epub 2006 Dec 22.

PMID:
17189592
16.

Function of the Th17/interleukin-17A immune response in murine lupus nephritis.

Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, Koyro T, Peters A, Velden J, Hünemörder S, Haag F, Steinmetz OM, Mittrücker HW, Stahl RA, Panzer U.

Arthritis Rheumatol. 2015 Feb;67(2):475-87. doi: 10.1002/art.38955.

17.

Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.

Zhang M, Yu G, Chan B, Pearson JT, Rathanaswami P, Delaney J, Ching Lim A, Babcook J, Hsu H, Gavin MA.

Arthritis Rheumatol. 2015 Oct;67(10):2723-31. doi: 10.1002/art.39233.

18.

Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.

Pau E, Chang NH, Loh C, Lajoie G, Wither JE.

Clin Immunol. 2011 May;139(2):215-27. doi: 10.1016/j.clim.2011.02.005. Epub 2011 Mar 17.

PMID:
21414847
19.

Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.

Rudofsky UH, Dilwith RL, Roths JB, Lawrence DA, Kelley VE, Magro AM.

Am J Pathol. 1984 Jul;116(1):107-14.

20.

Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation.

Bethunaickan R, Sahu R, Liu Z, Tang YT, Huang W, Edegbe O, Tao H, Ramanujam M, Madaio MP, Davidson A.

Arthritis Rheum. 2012 Oct;64(10):3399-408. doi: 10.1002/art.34553.

Supplemental Content

Support Center